Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBITDA Margin (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of EBITDA Margin data on record, last reported at 13.46% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1574.0% year-over-year to 13.46%; the TTM value through Dec 2025 reached 10.11%, up 669.0%, while the annual FY2025 figure was 8.52%, 328.0% up from the prior year.
  • EBITDA Margin reached 13.46% in Q4 2025 per PAHC's latest filing, up from 8.39% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 13.46% in Q4 2025 and bottomed at 2.28% in Q4 2024.
  • Average EBITDA Margin over 5 years is 5.85%, with a median of 7.56% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: crashed -756bps in 2021, then soared 1574bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 4.66% in 2021, then fell by -8bps to 4.28% in 2022, then plummeted by -76bps to 1.01% in 2023, then plummeted by -326bps to 2.28% in 2024, then skyrocketed by 691bps to 13.46% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 13.46% in Q4 2025, 8.39% in Q3 2025, and 8.9% in Q2 2025.